Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Terumo Corp. (OTCMKTS:TRUMY) was the target of a significant increase in short interest in May. As of May 29th, there was short interest totaling 147,141 shares, an increase of 946.0% from the May 14th total of 14,067 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 332,773 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on TRUMY shares. Nomura upgraded Terumo to a “hold” rating in a research report on Tuesday, February 24th. Zacks Research upgraded Terumo to a “hold” rating in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Terumo has a consensus rating of “Hold”.

Terumo Price Performance

OTCMKTS:TRUMY opened at $14.25 on Friday. Terumo has a one year low of $12.08 and a one year high of $19.60. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.89 and a current ratio of 1.59. The stock has a market cap of $21.02 billion, a PE ratio of 23.36 and a beta of 0.67. The stock has a 50 day moving average price of $13.67 and a 200 day moving average price of $13.81.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Equities research analysts expect that Terumo will post 0.63 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.